Nurix Therapeutics Chief Legal Officer Christine Ring reports common share disposal worth $134,160.79

• Christine Ring, Chief Legal Officer at Nurix Therapeutics, sold 5,786 common shares on Oct. 2, 2026 at USD 23.1851.
• Sale followed the exercise of 5,786 employee stock options at USD 8.72 on the same day.
• Directly held common shares fell to 9,110.
• Directly held employee stock options increased to 111,251.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817199-26-000032), on October 02, 2026, and is solely responsible for the information contained therein.